Presentation is loading. Please wait.

Presentation is loading. Please wait.

Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD 

Similar presentations


Presentation on theme: "Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD "— Presentation transcript:

1 Reduced High-density Lipoprotein Cholesterol in Patients Receiving Rosiglitazone and Fenofibrate 
Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD  The American Journal of Medicine  Volume 121, Issue 10, Pages e3-e4 (October 2008) DOI: /j.amjmed Copyright © 2008 Elsevier Inc. Terms and Conditions

2 Figure 1 Variation of serum HDL-C levels during therapy. The arrow (←) indicates cessation of rosiglitazone (patients 1 and 2) or fenofibrate (patient 3). HDL-C=high-density lipoprotein C. The American Journal of Medicine  , e3-e4DOI: ( /j.amjmed ) Copyright © 2008 Elsevier Inc. Terms and Conditions


Download ppt "Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD "

Similar presentations


Ads by Google